- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- January 2022
- 86 Pages
Global
From €3200EUR$3,767USD£2,839GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
The Epinephrine Injection market is a subset of the Infusions and Injectables market. It is composed of products used to treat anaphylaxis, a severe allergic reaction. These products are typically administered via an auto-injector, a device that injects a pre-measured dose of epinephrine into the patient. The market is composed of both branded and generic products, with the branded products typically being more expensive. The market is highly regulated, with the US Food and Drug Administration (FDA) requiring manufacturers to meet strict safety and efficacy standards.
Notable companies in the Epinephrine Injection market include Mylan, Sanofi, Teva Pharmaceuticals, Impax Laboratories, and Kaleo. Show Less Read more